Acquired resistance to immunotherapy in MMR-D pancreatic cancer

BACKGROUND: MMR-D pancreatic cancer have been reported to respond to checkpoint inhibitor therapy. Here, we report the first case of acquired resistance to immunotherapy in MMR-D pancreatic cancer. CASE PRESENTATION: A 45-year-old woman with unresectable MMR-D pancreatic cancer was initially treated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Hu, Zishuo Ian, Hellmann, Matthew D., Wolchok, Jedd D., Vyas, Monika, Shia, Jinru, Stadler, Zsofia K., Diaz, Luis A., O’Reilly, Eileen M.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6247688/
https://ncbi.nlm.nih.gov/pubmed/30458888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0448-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados